ELDN (Eledon Pharmaceuticals) Total Liabilities: $101.90 Mil (As of Mar. 2026)


ELDN Eledon Pharmaceuticals Inc ELDN
21 GF Score
Price $3.95
! 2 Warning Signs
View Full Analysis

What is Eledon Pharmaceuticals Total Liabilities?

Eledon Pharmaceuticals ELDN +1.28% 21 Total Liabilities is $101.90 Mil as of Mar. 2026. GuruFocus rates ELDN with a GF Score™ of 21/100. The stock has 2 warning signs investors should review.

Eledon Pharmaceuticals's Total Liabilities for the quarter that ended in Mar. 2026 was $101.90 Mil.

Eledon Pharmaceuticals's quarterly Total Liabilities declined from Sep. 2025 ($94.50 Mil) to Dec. 2025 ($87.92 Mil) but then increased from Dec. 2025 ($87.92 Mil) to Mar. 2026 ($101.90 Mil).

Eledon Pharmaceuticals's annual Total Liabilities increased from Dec. 2023 ($81.86 Mil) to Dec. 2024 ($114.96 Mil) but then declined from Dec. 2024 ($114.96 Mil) to Dec. 2025 ($87.92 Mil).

Eledon Pharmaceuticals Total Liabilities Historical Data

* Premium members only.

The historical data trend for Eledon Pharmaceuticals's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Eledon Pharmaceuticals Total Liabilities Chart

Eledon Pharmaceuticals Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 6.55 8.61 81.86 114.96 87.92

Eledon Pharmaceuticals Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 46.73 94.58 94.50 87.92 101.90
ELDN
21GF Score
Eledon Pharmaceuticals Inc ELDN
Total Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Eledon Pharmaceuticals Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Eledon Pharmaceuticals's Total Liabilities for the fiscal year that ended in Dec. 2025 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=18.344+(0.283+67.11
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+2.187+0+0)
=87.92

Total Liabilities=Total Assets (A: Dec. 2025 )-Total Equity (A: Dec. 2025 )
=169.009-81.085
=87.92

Eledon Pharmaceuticals's Total Liabilities for the quarter that ended in Mar. 2026 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=13.458+(0.186+86.072
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+2.187+0+0)
=101.90

Total Liabilities=Total Assets (Q: Mar. 2026 )-Total Equity (Q: Mar. 2026 )
=146.667-44.764
=101.90

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Liabilities →
What does a Total Liabilities of $101.90 Mil mean?
Eledon Pharmaceuticals (ELDN) has a Total Liabilities of $101.90 Mil as of Mar. 2026. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Eledon Pharmaceuticals and its competitors.
Is Eledon Pharmaceuticals' Total Liabilities too high?
Eledon Pharmaceuticals' current Total Liabilities is $101.90 Mil. Overall, Eledon Pharmaceuticals has a GF Score™ of 21/100, reflecting its overall financial health beyond just this single metric.
How does Eledon Pharmaceuticals' Total Liabilities compare to ZNTL and GLSI?
Eledon Pharmaceuticals' Total Liabilities of $101.90 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Liabilities for a Biotechnology company?
A good Total Liabilities depends on the Biotechnology industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Liabilities mean?
A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Eledon Pharmaceuticals and its competitors. Eledon Pharmaceuticals's current Total Liabilities is $101.90 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Eledon Pharmaceuticals stock overvalued right now?
Eledon Pharmaceuticals (ELDN) has a current Total Liabilities of $101.90 Mil. The current Total Liabilities is $101.90 Mil. Eledon Pharmaceuticals' overall GF Score™ is 21/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Liabilities calculated?
Total Liabilities is calculated from a company's financial statements. For Eledon Pharmaceuticals (ELDN), the current Total Liabilities is $101.90 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Eledon Pharmaceuticals Business Description

Other Exchanges 2TK:Germany
Address 19800 MacArthur Boulevard, Suite 250, Irvine, CA, USA, 92612
Eledon Pharmaceuticals Inc is a clinical stage biotechnology company using immunology expertise in targeting the CD40 Ligand pathway to develop therapies to protect transplanted organs and prevent rejection, and to treat amyotrophic lateral sclerosis. Its compound in development is tegoprubart, an IgG1, anti-CD40L antibody with high affinity for the CD40L, a well-validated biological target that has broad therapeutic potential. It operates as one reportable segment, focused on the development of tegoprubart, to develop therapies to protect transplanted organs and prevent rejection, and to treat ALS.
21GF Score

Get the complete analysis for ELDN

Total Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$3.95
Price